SCHEMBL7235019

SCHEMBL7235019

O=C(N[C@@H]1C[C@H]2CC[C@@H]1N2)c1cc(-c2ccccc2)c(Cl)s1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
KDR P35968 1/20 0.38
PLK1 P53350 1/20 0.38
CCNA1 P78396 1/20 0.38
AKT1 P31749 2/20 0.37
HTR3E A5X5Y0 4/20 0.36
HTR3B O95264 4/20 0.36
HTR3A P46098 4/20 0.36
HTR3D Q70Z44 4/20 0.36
HTR3C Q8WXA8 4/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNA4 P43681 1/20 0.36
CHRNA7 P36544 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7230705 0.87 HTR3E (0.39) CCNA2CDK2KDRPLK1CCNA1
SCHEMBL7225954 0.85 CCNA2 (0.38) CCNA2CDK2KDRPLK1CCNA1
SCHEMBL7226779 0.84 HTR3E (0.41) CCNA2CDK2KDRPLK1CCNA1
SCHEMBL7223931 0.84 CTSC (0.39) CCNA2CDK2KDRPLK1CCNA1
SCHEMBL7224419 0.81 MEN1 (0.36) AKT1HTR3ACHRNB2CHRNA4CHRNA7
SCHEMBL7225207 0.81 DAO (0.42) AKT1HTR3ACHRNB2CHRNA4CHRNA7
SCHEMBL7226905 0.80 HPGD (0.54) CCNA2CDK2KDRPLK1CCNA1
SCHEMBL375517 0.80 CHRNA7 (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7223338 0.80 CHRNA7 (0.57) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7225843 0.79 USP30 (0.49) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US claimed
US-6562816-B2 Alpha 7 nicotine acetylcholine receptor agonist anti-psychotic agent, with reduced side effects PHARMACIA & UPJOHN COMPANY 2003-05-13 US disclosed